SK114498A3 - Imidazo triazolo pyrimidinone derivatives, method of preparing them and their use - Google Patents
Imidazo triazolo pyrimidinone derivatives, method of preparing them and their use Download PDFInfo
- Publication number
- SK114498A3 SK114498A3 SK1144-98A SK114498A SK114498A3 SK 114498 A3 SK114498 A3 SK 114498A3 SK 114498 A SK114498 A SK 114498A SK 114498 A3 SK114498 A3 SK 114498A3
- Authority
- SK
- Slovakia
- Prior art keywords
- optionally substituted
- alkyl
- phenyl
- benzyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19629378A DE19629378A1 (de) | 1996-07-20 | 1996-07-20 | Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP1997/003841 WO1998003511A1 (de) | 1996-07-20 | 1997-07-17 | Neue triazolopurine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
CA002242097A CA2242097C (en) | 1996-07-20 | 1998-06-26 | Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SK114498A3 true SK114498A3 (en) | 1999-02-11 |
Family
ID=32963000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1144-98A SK114498A3 (en) | 1996-07-20 | 1997-07-17 | Imidazo triazolo pyrimidinone derivatives, method of preparing them and their use |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP0880524B1 (cs) |
JP (1) | JP3020281B2 (cs) |
CN (1) | CN1219936A (cs) |
AT (1) | ATE191913T1 (cs) |
AU (1) | AU3695597A (cs) |
BG (1) | BG102707A (cs) |
BR (1) | BR9710747A (cs) |
CA (1) | CA2256736A1 (cs) |
CZ (1) | CZ265498A3 (cs) |
DE (2) | DE19629378A1 (cs) |
DK (1) | DK0880524T3 (cs) |
EE (1) | EE9800451A (cs) |
ES (1) | ES2147453T3 (cs) |
GR (1) | GR3033842T3 (cs) |
HR (1) | HRP970395A2 (cs) |
HU (1) | HUP9902311A3 (cs) |
ID (1) | ID19106A (cs) |
IL (1) | IL126453A0 (cs) |
NO (1) | NO983860L (cs) |
PL (1) | PL328824A1 (cs) |
PT (1) | PT880524E (cs) |
SK (1) | SK114498A3 (cs) |
TR (1) | TR199801659T2 (cs) |
WO (1) | WO1998003511A1 (cs) |
ZA (1) | ZA976331B (cs) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19826843A1 (de) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2000012511A1 (de) * | 1998-08-27 | 2000-03-09 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidine |
US6492377B1 (en) | 1998-06-25 | 2002-12-10 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines with adenosine-antagonistic activity |
US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
CA2656039A1 (en) | 2006-06-23 | 2007-12-27 | Incyte Corporation | Purinone derivatives as hm74a agonists |
MA52422A (fr) | 2018-02-27 | 2021-01-06 | Incyte Corp | Imidazopyrimidines et triazolopyrimidines en tant qu'inhibiteurs a2a/a2b |
WO2019222677A1 (en) | 2018-05-18 | 2019-11-21 | Incyte Corporation | Fused pyrimidine derivatives as a2a / a2b inhibitors |
MA53097A (fr) | 2018-07-05 | 2021-05-12 | Incyte Corp | Dérivés de pyrazine fusionnés en tant qu'inhibiteurs d'a2a/a2b |
TW202039496A (zh) | 2018-11-30 | 2020-11-01 | 美商默沙東藥廠 | 做為腺苷受體拮抗劑之9-經取代胺基三唑喹唑啉衍生物、醫藥組合物及其用途 |
TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
CN112778311B (zh) * | 2019-11-01 | 2024-06-04 | 上海翰森生物医药科技有限公司 | 含氮并环类衍生物抑制剂、其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA902282B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor compounds |
IT1264901B1 (it) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
JPH083169A (ja) * | 1994-06-15 | 1996-01-09 | Yamasa Shoyu Co Ltd | 4−メチル−1H−[1,2,4]トリアゾロ[1,5−a]プリン−9(4H)−オン類 |
-
1996
- 1996-07-20 DE DE19629378A patent/DE19629378A1/de not_active Withdrawn
-
1997
- 1997-07-17 CA CA002256736A patent/CA2256736A1/en not_active Abandoned
- 1997-07-17 PL PL97328824A patent/PL328824A1/xx unknown
- 1997-07-17 DK DK97933683T patent/DK0880524T3/da active
- 1997-07-17 EE EE9800451A patent/EE9800451A/xx unknown
- 1997-07-17 DE DE59701467T patent/DE59701467D1/de not_active Expired - Lifetime
- 1997-07-17 CN CN97194506A patent/CN1219936A/zh active Pending
- 1997-07-17 EP EP97933683A patent/EP0880524B1/de not_active Expired - Lifetime
- 1997-07-17 AU AU36955/97A patent/AU3695597A/en not_active Abandoned
- 1997-07-17 HU HU9902311A patent/HUP9902311A3/hu unknown
- 1997-07-17 JP JP10505626A patent/JP3020281B2/ja not_active Expired - Fee Related
- 1997-07-17 WO PCT/EP1997/003841 patent/WO1998003511A1/de not_active Application Discontinuation
- 1997-07-17 CZ CZ982654A patent/CZ265498A3/cs unknown
- 1997-07-17 BR BR9710747A patent/BR9710747A/pt unknown
- 1997-07-17 TR TR1998/01659T patent/TR199801659T2/xx unknown
- 1997-07-17 SK SK1144-98A patent/SK114498A3/sk unknown
- 1997-07-17 EP EP99119410A patent/EP0978517A3/de not_active Withdrawn
- 1997-07-17 PT PT97933683T patent/PT880524E/pt unknown
- 1997-07-17 ZA ZA976331A patent/ZA976331B/xx unknown
- 1997-07-17 ES ES97933683T patent/ES2147453T3/es not_active Expired - Lifetime
- 1997-07-17 AT AT97933683T patent/ATE191913T1/de active
- 1997-07-17 IL IL12645397A patent/IL126453A0/xx unknown
- 1997-07-18 ID IDP972495A patent/ID19106A/id unknown
- 1997-07-18 HR HR19629378.2A patent/HRP970395A2/hr not_active Application Discontinuation
-
1998
- 1998-08-20 BG BG102707A patent/BG102707A/xx unknown
- 1998-08-21 NO NO983860A patent/NO983860L/no not_active Application Discontinuation
-
2000
- 2000-06-30 GR GR20000401543T patent/GR3033842T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BG102707A (bg) | 1999-09-30 |
BR9710747A (pt) | 1999-08-17 |
NO983860L (no) | 1998-10-21 |
NO983860D0 (no) | 1998-08-21 |
CA2256736A1 (en) | 1998-01-29 |
DE59701467D1 (de) | 2000-05-25 |
AU3695597A (en) | 1998-02-10 |
EE9800451A (et) | 1999-06-15 |
PL328824A1 (en) | 1999-02-15 |
ES2147453T3 (es) | 2000-09-01 |
EP0880524B1 (de) | 2000-04-19 |
EP0880524A1 (de) | 1998-12-02 |
EP0978517A3 (de) | 2003-11-12 |
EP0978517A2 (de) | 2000-02-09 |
DE19629378A1 (de) | 1998-01-29 |
CZ265498A3 (cs) | 1998-12-16 |
DK0880524T3 (da) | 2000-07-17 |
ID19106A (id) | 1998-06-18 |
HRP970395A2 (en) | 1998-08-31 |
ATE191913T1 (de) | 2000-05-15 |
JP3020281B2 (ja) | 2000-03-15 |
JP2000501420A (ja) | 2000-02-08 |
HUP9902311A2 (hu) | 1999-10-28 |
ZA976331B (en) | 1999-01-25 |
CN1219936A (zh) | 1999-06-16 |
HUP9902311A3 (en) | 2000-06-28 |
WO1998003511A1 (de) | 1998-01-29 |
TR199801659T2 (xx) | 1998-12-21 |
GR3033842T3 (en) | 2000-10-31 |
PT880524E (pt) | 2000-07-31 |
IL126453A0 (en) | 1999-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2457944C (en) | Polycyclic guanine phosphodiesterase v inhibitors | |
US5736549A (en) | Hypoxanthine and guanine compounds | |
EP1116722B1 (en) | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES | |
CA2140883A1 (en) | Asymmetrically substituted xanthines | |
CA2112031A1 (en) | Xanthine derivatives | |
JPS63297381A (ja) | 9−〔2−(ヒドロキシメチル)シクロアルキルメチル〕グアニン類 | |
SK114498A3 (en) | Imidazo triazolo pyrimidinone derivatives, method of preparing them and their use | |
EP0156559B1 (en) | 8-substituted guanine derivatives | |
JP3116230B2 (ja) | 三環式縮合ピリミジン誘導体 | |
CA3158731A1 (en) | Adenosine receptor antagonist compounds | |
EP1492793B1 (en) | New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives | |
AU632914B2 (en) | Selective adenosine receptor agents | |
DE19816857A1 (de) | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
US6492377B1 (en) | Imidazotriazolopyrimidines with adenosine-antagonistic activity | |
JP4567883B2 (ja) | 新規イミダゾトリアゾロピリミジン、それらの調製方法及び医薬組成物としてのそれらの使用 | |
KR20000064893A (ko) | 트리아졸로퓨린,이의제조방법및이를함유하는약제학적제제 | |
JPS61227584A (ja) | ポリアザ複素環誘導体 | |
JPWO2003020723A1 (ja) | [1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体 | |
CA2242097C (en) | Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions | |
US6949652B2 (en) | Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine | |
AU1741899A (en) | New imidazotriazolopyrimidinones, processes for preparing them and their use as pharmaceutical compositions | |
JPS60248690A (ja) | グアニン誘導体 | |
HK1064668B (en) | Polycyclic guanine phosphodiesterase v inhibitors |